Showing Results for
- Academic Journals (69)
Search Results
- 69
Academic Journals
- 69
- Search Terms:ISSN: 1750743XAndISSN: 17507448AndVolume Number: 2AndIssue Number: 4AndStart Page: 575AndDate: 2010 Revise Search
- 1From: Immunotherapy. (Vol. 2, Issue 2) Peer-ReviewedAn investigational vaccine for non-Hodgkin's lymphoma (NHL) is now being tested in human subjects. This is the first time that proteins obtained from tobacco plants using magnICON® (Hamburg, Germany) technologies are...
- 2From: Immunotherapy. (Vol. 2, Issue 1) Peer-ReviewedAuthor(s): Kate O'Brien 1 , Bruno Gran 1 2 , Abdolmohamad Rostami [[dagger]] 2 KEYWORDS : disease-modifying treatment; experimental autoimmune encephalomyelitis; immune system; immunotherapy; multiple...
- 3From: Immunotherapy. (Vol. 2, Issue 6) Peer-ReviewedAuthor(s): James Ferrara 1 2 , Pavan Reddy 2 , Sophie Paczesny [[dagger]] 3 KEYWORDS : autoimmunity; graft-versus-host disease; immunotherapy; mixed dimers; TCR cross-pairing; TCR gene therapy; TCR gene...
- 4From: Immunotherapy. (Vol. 2, Issue 2) Peer-ReviewedAuthor(s): Elzbieta Pajtasz-Piasecka [[dagger]] 1 , Marie Indrová 2 KEYWORDS: dendritic cell; experimental tumor; preparation of vaccine Dendritic cells (DCs) are believed to be the most efficient...
- 5From: Immunotherapy. (Vol. 2, Issue 5) Peer-ReviewedAuthor(s): Yoshihiro Oka [[dagger]] 1 , Haruo Sugiyama 2 KEYWORDS: cancer antigen; peptide vaccine; WT1 WT1 has features appropriate for a cancer antigen It has been demonstrated that T-cell-mediated...
- 6From: Immunotherapy. (Vol. 2, Issue 1) Peer-ReviewedAuthor(s): Glenda Canderan 1 , Paolo Dellabona [[dagger]] 2 KEYWORDS : adoptive immunotherapy; Th17 cells; tumor immunology; vaccines Naive CD4+ T helper (Th) cells give rise to different types of effector...
- 7From: Immunotherapy. (Vol. 2, Issue 5) Peer-ReviewedAuthor(s): Donald R Shaffer 1 , Cliona M Rooney 1 , Stephen Gottschalk [[dagger]] 2 KEYWORDS: Epstein-Barr virus; lymphoproliferative disease; monoclonal antibody; rituximab; T-cell therapy; transplantation An...
- 8From: Immunotherapy. (Vol. 2, Issue 3) Peer-ReviewedAuthor(s): Myriam N Bouchlaka 1 , Doug Redelman 2 , William J Murphy [[dagger]â ] 3 KEYWORDS : adoptive immunotherapy; antigen-presenting cell; graft-versus-host disease; graft-versus-leukemia;...
- 9From: Immunotherapy. (Vol. 2, Issue 3) Peer-ReviewedAuthor(s): Toral Kamdar 1 , Paul J Bryce [[dagger]â ] 2 KEYWORDS : food allergy; food hypersensitivity; immunotherapy; oral immunotherapy; sublingual immunotherapy Food allergy: epidemiology Food...
- 10From: Immunotherapy. (Vol. 2, Issue 1) Peer-ReviewedAuthor(s): Nona Janikashvili 1 , Nicolas Larmonier 1 2 , Emmanuel Katsanis [[dagger]] 1 2 3 KEYWORDS : anticancer immune response; chaperone protein; dendritic cell; idiotype; personalized tumor vaccine; tumor...
- 11From: Immunotherapy. (Vol. 2, Issue 5) Peer-ReviewedAuthor(s): Richard Warrington 1 KEYWORDS: anticytokines; asthma; cytokines; immunotherapy It is currently perceived that there is an asthma epidemic [1] . In North America, allergic diseases affect...
- 12From: Immunotherapy. (Vol. 2, Issue 2) Peer-ReviewedAuthor(s): Diana Dlugovitzky 1 , Rodolfo Notario 1 , Diego Martinel-Lamas 1 , Gladys Fiorenza 1 , Miguel Farroni 2 , Christina Bogue 2 , Cynthia Stanford 3 , John Stanford [[dagger]] 3 KEYWORDS: immunological...
- 13From: Immunotherapy. (Vol. 2, Issue 6) Peer-ReviewedAuthor(s): Meghan E Turnis 1 , Cliona M Rooney [[dagger]] 2 KEYWORDS : cancer immunotherapy; dendritic cell; genetic modification; immunology; tumor immunity; vaccine Dendritic cells & stimulation of the...
- 14From: Immunotherapy. (Vol. 2, Issue 2) Peer-ReviewedAuthor(s): Yoshihiko Hirohashi 1 , Toshihiko Torigoe 1 , Satoko Inoda 1 , Akari Takahashi 1 , Rena Morita 1 , Satoshi Nishizawa 1 , Yasuaki Tamura 1 , Hiromu Suzuki 2 , Minoru Toyota 2 , Noriyuki Sato [[dagger]] 1...
- 15From: Immunotherapy. (Vol. 2, Issue 6) Peer-ReviewedAuthor(s): Huguette Albrecht 1 KEYWORDS : breast cancer; combination therapy; HER2; resistance; trastuzumab Since its approval by the US FDA in 1998, trastuzumab (Herceptin® ; Genentech, CA, USA) has become...
- 16From: Immunotherapy. (Vol. 2, Issue 3) Peer-ReviewedAuthor(s): Sandra Waalkes 1 , Mario Kramer 1 , Thomas RW Herrmann 1 , Andres J Schrader 2 , Markus A Kuczyk [[dagger]â ] 3 , Axel S Merseburger 1 KEYWORDS : metastasis; prognosis; renal cell carcinoma; targeted...
- 17From: Immunotherapy. (Vol. 2, Issue 1) Peer-Reviewed
Immunotherapy and neuroimmunology in Alzheimer's disease: a perspective from the blood-brain barrier
Author(s): William A Banks 1 Interactions between the CNS and the immune system were once considered to be rare. One reason for the division between these systems was thought to be the blood-brain barrier (BBB),... - 18From: Immunotherapy. (Vol. 2, Issue 6) Peer-ReviewedAuthor(s): Beatrix Kotlan 1 Since the first meeting in Orlando (FL, USA) in 1990, the International Conference on Human Antibodies and Hybridomas (HAH) was once again perfectly organized for the 15th time, in Porto...
- 19From: Immunotherapy. (Vol. 2, Issue 5) Peer-ReviewedAuthor(s): Pierre Youinou 1 The 7th International Congress on Autoimmunity was held in Slovenia, 5-9 May 2010. This series of meetings was initiated in Tel Aviv, Israel in 1994, and has been organized since then by...
- 20From: Immunotherapy. (Vol. 2, Issue 2) Peer-ReviewedAuthor(s): David S Ritchie [[dagger]] 1 2 3 , Hang Quach 1 4 , Kate Fielding 1 , Paul Neeson 1 KEYWORDS: adoptive immunotherapy; immunogenic cell death; immunomodulatory drug; myeloma; vaccination The standard...